Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
22.34
+0.55 (2.52%)
At close: Aug 28, 2025, 4:00 PM
22.75
+0.41 (1.84%)
After-hours: Aug 28, 2025, 7:45 PM EDT
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of $3.09 billion as of August 28, 2025. Its market cap has increased by 8.31% in one year.
Market Cap
3.09B
Enterprise Value
2.90B
1-Year Change
8.31%
Ranking
Category
Stock Price
$22.34
Market Cap Chart
Since June 30, 2004, Arrowhead Pharmaceuticals's market cap has increased from $95.40M to $3.09B, an increase of 3,137.60%. That is a compound annual growth rate of 17.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 27, 2025 | 3.01B | 28.78% |
Dec 31, 2024 | 2.34B | -28.84% |
Dec 29, 2023 | 3.29B | -23.54% |
Dec 30, 2022 | 4.30B | -37.84% |
Dec 31, 2021 | 6.92B | -11.95% |
Dec 31, 2020 | 7.86B | 29.67% |
Dec 31, 2019 | 6.06B | 451.13% |
Dec 31, 2018 | 1.10B | 299.42% |
Dec 29, 2017 | 275.20M | 154.58% |
Dec 30, 2016 | 108.10M | -70.48% |
Dec 31, 2015 | 366.20M | -9.27% |
Dec 31, 2014 | 403.60M | -3.88% |
Dec 31, 2013 | 419.90M | 1,153.43% |
Dec 31, 2012 | 33.50M | -24.04% |
Dec 30, 2011 | 44.10M | -31.42% |
Dec 31, 2010 | 64.30M | 93.09% |
Dec 31, 2009 | 33.30M | -15.70% |
Dec 31, 2008 | 39.50M | -72.93% |
Dec 31, 2007 | 145.90M | -2.60% |
Dec 29, 2006 | 149.80M | 25.99% |
Dec 30, 2005 | 118.90M | 101.87% |
Dec 31, 2004 | 58.90M | -38.26% |
Jun 30, 2004 | 95.40M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.09B |
Johnson & Johnson | 425.77B |
AbbVie | 367.55B |
UnitedHealth Group | 275.22B |
AstraZeneca | 248.07B |
Novo Nordisk | 246.45B |
Novartis AG | 245.68B |
Abbott Laboratories | 228.80B |